PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company engaged in the discovery & development of RNA-based therapeutics for the treatment of severe genetic disorders.

$0.76  -0.01 (-1.29%)
As of 09/23/2022 16:30:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  The Netherlands
Country of incorporation:  The Netherlands
IPO date:  09/18/2014
Outstanding shares:  71,290,805
Average volume:  259,551
Market cap:   $54,188,141
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      BQRX1W2
Valuation   (See tab for details)
PE ratio:   -0.87
PB ratio:   0.54
PS ratio:   19.86
Return on equity:   -62.93%
Net income %:   -2,451.93%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy